Skip to main content

Mouse CCL17/TARC Antibody

R&D Systems, part of Bio-Techne | Catalog # AF529

R&D Systems, part of Bio-Techne
Catalog #
Availability
Size / Price
Qty
Loading...
AF529
AF529-SP

Key Product Details

Species Reactivity

Validated:

Mouse

Cited:

Mouse

Applications

Validated:

Neutralization, Western Blot

Cited:

Confocal Microscopy, Flow Cytometry, Immunocytochemistry, In vivo assay, Neutralization, Western Blot

Label

Unconjugated

Antibody Source

Polyclonal Goat IgG

Product Specifications

Immunogen

E. coli-derived recombinant mouse CCL17/TARC
Ala24-Pro93
Accession # Q9WUZ6

Specificity

Detects mouse CCL17/TARC in direct ELISAs and Western blots. In direct ELISAs, approximately 25% cross-reactivity with recombinant human TARC is observed. Neutralizes the biological activity of recombinant mouse TARC, and will also neutralize the biological activity of recombinant human TARC using a 20 fold greater Ig concentration.

Clonality

Polyclonal

Host

Goat

Isotype

IgG

Endotoxin Level

<0.10 EU per 1 μg of the antibody by the LAL method.

Scientific Data Images for Mouse CCL17/TARC Antibody

Chemotaxis Induced by CCL17/TARC and Neutralization by Mouse CCL17/TARC Antibody.

Chemotaxis Induced by CCL17/TARC and Neutralization by Mouse CCL17/TARC Antibody.

Recombinant Mouse CCL17/ TARC (Catalog # 529-TR) chemoattracts the BaF3 mouse pro-B cell line transfected with human CCR4 in a dose-dependent manner (orange line). The amount of cells that migrated through to the lower chemotaxis chamber was measured by Resazurin (Catalog # AR002). Chemotaxis elicited by Recombinant Mouse CCL17/TARC (0.02 µg/mL) is neutralized (green line) by increasing concentrations of Goat Anti-Mouse CCL17/TARC Antigen Affinity-purified Polyclonal Antibody (Catalog # AF529). The ND50 is typically 0.2-0.6 µg/mL.
Detection of Mouse CCL17/TARC by Immunocytochemistry/ Immunofluorescence

Detection of Mouse CCL17/TARC by Immunocytochemistry/ Immunofluorescence

Cd248 disruption reduced infiltration and pro-fibrotic phenotype switching of kidney macrophages during renal fibrosis. (a) Representative images of F4/80 immunostaining for macrophages in control and D14 UUO kidneys. F4/80+ staining was brown. Original magnification, × 100. Scale bar, 100 μm. (b) Quantification of F4/80+ areas on LPF images of kidney sections taken at 100 × magnification n = 10. (c). Representative images of green fluorescent protein (GFP)+ circulation-derived cells and F4/80+ (red) macrophages in control and day 3 (D3) UUO-kidneys of WT and Cd248–/– parabionts joined surgically to transgenic GFP (GFPTg) mice. Arrowhead indicates an F4/80+GFP+ macrophage. Original magnification, × 100. Scale bar, 100 μm. (d) Quantification of GFP+, F4/80+ and F4/80+GFP+ cells on LPF images of control (upper panel) and D3 UUO (lower panel) kidneys of WT and Cd248–/– parabionts. n = 3. (e) qPCR of genes encoding cytokines and enzymes in macrophages isolated from D7 UUO kidneys. n = 4. (f) qPCR of Nos2, Arg1 and Ccl17 in lipopolysaccharide (LPS) and interferon gamma (IFN gamma)–primed RAW264.7 macrophages co-cultured with D7 UUO-kidney myofibroblasts isolated from WT or Cd248–/– mice in the Transwell system. RAW264.7 macrophages co-cultured with medium were used as control. n = 4. (g) qPCR of Ccl17 in WT bone marrow–derived macrophages (BMDMs, Mϕ) co-cultured with medium only (control) or with WT or Cd248–/– UUO-kidney myofibroblasts (MF) in the same dish. Recombinant CD248 (rCD248) was included in the culture as indicated. n = 5. Data are expressed as means ± standard errors of the mean. *P < 0.05, **P < 0.01, ***P < 0.001 by one-way ANOVA with post hoc Tukey’s multiple comparisons test in (b,g) and unpaired t-test in (d,e,f). Image collected and cropped by CiteAb from the following open publication (https://pubmed.ncbi.nlm.nih.gov/33033277), licensed under a CC-BY license. Not internally tested by R&D Systems.
Detection of Mouse CCL17/TARC by Immunocytochemistry/ Immunofluorescence

Detection of Mouse CCL17/TARC by Immunocytochemistry/ Immunofluorescence

Cd248 disruption reduced infiltration and pro-fibrotic phenotype switching of kidney macrophages during renal fibrosis. (a) Representative images of F4/80 immunostaining for macrophages in control and D14 UUO kidneys. F4/80+ staining was brown. Original magnification, × 100. Scale bar, 100 μm. (b) Quantification of F4/80+ areas on LPF images of kidney sections taken at 100 × magnification n = 10. (c). Representative images of green fluorescent protein (GFP)+ circulation-derived cells and F4/80+ (red) macrophages in control and day 3 (D3) UUO-kidneys of WT and Cd248–/– parabionts joined surgically to transgenic GFP (GFPTg) mice. Arrowhead indicates an F4/80+GFP+ macrophage. Original magnification, × 100. Scale bar, 100 μm. (d) Quantification of GFP+, F4/80+ and F4/80+GFP+ cells on LPF images of control (upper panel) and D3 UUO (lower panel) kidneys of WT and Cd248–/– parabionts. n = 3. (e) qPCR of genes encoding cytokines and enzymes in macrophages isolated from D7 UUO kidneys. n = 4. (f) qPCR of Nos2, Arg1 and Ccl17 in lipopolysaccharide (LPS) and interferon gamma (IFN gamma)–primed RAW264.7 macrophages co-cultured with D7 UUO-kidney myofibroblasts isolated from WT or Cd248–/– mice in the Transwell system. RAW264.7 macrophages co-cultured with medium were used as control. n = 4. (g) qPCR of Ccl17 in WT bone marrow–derived macrophages (BMDMs, Mϕ) co-cultured with medium only (control) or with WT or Cd248–/– UUO-kidney myofibroblasts (MF) in the same dish. Recombinant CD248 (rCD248) was included in the culture as indicated. n = 5. Data are expressed as means ± standard errors of the mean. *P < 0.05, **P < 0.01, ***P < 0.001 by one-way ANOVA with post hoc Tukey’s multiple comparisons test in (b,g) and unpaired t-test in (d,e,f). Image collected and cropped by CiteAb from the following open publication (https://pubmed.ncbi.nlm.nih.gov/33033277), licensed under a CC-BY license. Not internally tested by R&D Systems.

Applications for Mouse CCL17/TARC Antibody

Application
Recommended Usage

Western Blot

0.1 µg/mL
Sample: Recombinant Mouse CCL17/TARC (Catalog # 529-TR)

Neutralization

Measured by its ability to neutralize CCL17/TARC-induced chemotaxis in the BaF3 mouse pro-B cell line transfected with human CCR4. The Neutralization Dose (ND50) is typically 0.2-0.6 µg/mL in the presence of 0.02 µg/mL Recombinant Mouse CCL17/TARC.
Please Note: Optimal dilutions of this antibody should be experimentally determined.

Reviewed Applications

Read 2 reviews rated 5 using AF529 in the following applications:

Formulation, Preparation, and Storage

Purification

Antigen Affinity-purified

Reconstitution

Reconstitute at 0.2 mg/mL in sterile PBS. For liquid material, refer to CoA for concentration.

Reconstitution Buffer Available:
Size / Price
Qty
Loading...

Formulation

Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied either lyophilized or as a 0.2 µm filtered solution in PBS.

Shipping

Lyophilized product is shipped at ambient temperature. Liquid small pack size (-SP) is shipped with polar packs. Upon receipt, store immediately at the temperature recommended below.

Stability & Storage

Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
  • 12 months from date of receipt, -20 to -70 °C as supplied.
  • 1 month, 2 to 8 °C under sterile conditions after reconstitution.
  • 6 months, -20 to -70 °C under sterile conditions after reconstitution.

Background: CCL17/TARC

Human thymus and activation-regulated chemokine (TARC) also known as CCL17, is a novel CC chemokine identified using a signal sequence trap method. Mouse TARC was discovered as a dendritic cell (DC) specific gene by differentiation RNA display. Mouse TARC cDNA encodes a highly basic 93 amino acid (aa) residue precursor protein with a 23 aa residue putative signal peptide that is cleaved to generate the 70 aa residue mature secreted protein. Among CC chemokine family members, TARC has approximately 24 - 29% amino acid sequence identity with RANTES, MIP-1 alpha, MIP-1 beta, MCP-1, MCP-2, MCP-3 and I-309. The gene for human TARC has been mapped to chromosome 16q13 rather than chromosome 17 where the genes for many human CC chemokines are clustered. Mouse TARC is constitutively expressed in thymic DC, and at a lower level in lymph node DC in the lung. Recombinant TARC has been shown to be chemotactic for T cell lines and antigen-primed T helper cells. In humans, TARC was identified to be a specific functional ligand for CCR-4 and CCR-8, receptors that are selectively expressed on T cells.

References

  1. Imai, T. et al. (1997) J. Biol. Chem. 272:15036.
  2. Imai, T. et al. (1996) J. Biol. Chem. 271:21514.
  3. Nomiyama, H. et al. (1997) Genomics 40:211.
  4. Lieberam, I. et al. (1999) Eur. J. Immunol. 29:2684.

Alternate Names

ABCD-2, SCYA17, TARC

Entrez Gene IDs

6361 (Human); 20295 (Mouse)

Gene Symbol

CCL17

UniProt

Additional CCL17/TARC Products

Product Documents for Mouse CCL17/TARC Antibody

Certificate of Analysis

To download a Certificate of Analysis, please enter a lot number in the search box below.

Note: Certificate of Analysis not available for kit components.

Product Specific Notices for Mouse CCL17/TARC Antibody

For research use only

Loading...
Loading...
Loading...
Loading...